메뉴 건너뛰기




Volumn 71, Issue 4, 2011, Pages 608-610

Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion

Author keywords

Inhalation; Lung; Terbutaline; Urinary excretion

Indexed keywords

ACTIVATED CARBON; TERBUTALINE SULFATE;

EID: 79952576989     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03873.x     Document Type: Article
Times cited : (44)

References (7)
  • 1
    • 0024993410 scopus 로고
    • A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline
    • Borgstrom L, Nilsson M. A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline. Pharm Res 1990; 7: 1068-70.
    • (1990) Pharm Res , vol.7 , pp. 1068-1070
    • Borgstrom, L.1    Nilsson, M.2
  • 2
    • 0026799488 scopus 로고
    • Determination of the relative bioavailability of salbutamol to the lung following inhalation
    • Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34: 311-5.
    • (1992) Br J Clin Pharmacol , vol.34 , pp. 311-315
    • Hindle, M.1    Chrystyn, H.2
  • 3
    • 66049153694 scopus 로고    scopus 로고
    • New HPLC assay for urinary salbutamol concentrations in samples collected post inhalation
    • Mazhar S, Chrystyn H. New HPLC assay for urinary salbutamol concentrations in samples collected post inhalation. J Pharm Biomed Anal 2009; 50: 175-82.
    • (2009) J Pharm Biomed Anal , vol.50 , pp. 175-182
    • Mazhar, S.1    Chrystyn, H.2
  • 4
    • 0043031108 scopus 로고    scopus 로고
    • Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation
    • Tomlinson HS, Corlett SA, Chrystyn H. Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation. Br J Clin Pharmacol 2003; 56: 225-7.
    • (2003) Br J Clin Pharmacol , vol.56 , pp. 225-227
    • Tomlinson, H.S.1    Corlett, S.A.2    Chrystyn, H.3
  • 5
    • 0028359883 scopus 로고
    • Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices
    • Hindle M, Chrystyn H, Newton DA. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices. Thorax 1994; 49: 549-53.
    • (1994) Thorax , vol.49 , pp. 549-553
    • Hindle, M.1    Chrystyn, H.2    Newton, D.A.3
  • 6
    • 0036042158 scopus 로고    scopus 로고
    • Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization
    • Silkstone VL, Corlett SA, Chrystyn H, Tomlinson HS. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization. Br J Clin Pharmacol 2002; 54: 115-9.
    • (2002) Br J Clin Pharmacol , vol.54 , pp. 115-119
    • Silkstone, V.L.1    Corlett, S.A.2    Chrystyn, H.3    Tomlinson, H.S.4
  • 7
    • 0034895786 scopus 로고    scopus 로고
    • European Respiratory Society Guidelines on the use of nebulizers: guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers
    • Members of Task Force
    • Boe J, Dennis J, O'Driscoll B, Members of Task Force: Bauer T, Carone M, Dautzenberg B, Diot P, Heslop K, Lannefors L. European Respiratory Society Guidelines on the use of nebulizers: guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers. Eur Respir J 2001; 18: 228-42.
    • (2001) Eur Respir J , vol.18 , pp. 228-242
    • Boe, J.1    Dennis, J.2    O'Driscoll, B.3    Bauer, T.4    Carone, M.5    Dautzenberg, B.6    Diot, P.7    Heslop, K.8    Lannefors, L.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.